Stock FOXO FOXO TECHNOLOGIES INC.
Add to a list
To use this feature you must be a member
Log inSign up

Press Releases FOXO Technologies Inc.

Equities

FOXO

US3514713052

Real-time Estimate Cboe BZX
Other stock markets
 09:40:29 21/05/2024 pm IST 		5-day change 1st Jan Change
0.293 USD -1.55% Intraday chart for FOXO Technologies Inc. -2.98% -9.23%
28/04 FOXO Technologies Inc. announced that it has received $0.11 million in funding from LGH Investments, LLC CI
24/04 Sector Update: Tech Stocks Higher Premarket Wednesday MT

Press Releases

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
FOXO Technologies Inc. Announces Receipt of Notice of Non-Compliance with NYSE Continued Listing Requirements
AQ
FOXO Technologies Announces Non-Binding Agreement for Potentially Transformative Merger with M2i Global
AQ
FOXO Technologies Announces Appointment of Capital Markets Veteran Francis Colt deWolf to the Board of Directors
BU
FOXO Technologies Formalizes License Agreement with KR8.ai to Power New Epigenetic Wellness Solutions
BU
FOXO Technologies Inc. Announces Receipt of Notice of Non-Compliance with NYSE Continued Listing Requirements
BU
FOXO Technologies On Track to Commence Commercial Rollout of VITHAR™ AI Health Coach in Early 2024
BU
FOXO Technologies Receives Notice from NYSE American Regarding Late Filing of Quarterly Report on Form 10-Q
BU
FOXO Technologies Provides Reminder for Webinar to be Held Today, November 10th at 10 AM Eastern Time, to Unveil VITHAR™ AI Health Coach
BU
FOXO Technologies to Unveil VITHAR™ AI Health Coach; Schedules Webinar for Friday, November 10th at 10 AM Eastern Time
BU
FOXO Technologies Expects Class A Common Stock to Resume Trading, Today, November 7, in Connection with 1-for-10 Reverse Stock Split
BU
FOXO Technologies Unveils Plans for New Direct-to Consumer Offering Combining the Company’s Epigenetic Data with the Power of AI
BU
FOXO Technologies Inc. Announces Reverse Stock Split
BU
FOXO Technologies Completes Strategic Alternatives Review and Outlines Latest Progress Executing Corporate Strategy
BU
FOXO Technologies Announces Issue Notification from USPTO for a Patent Leveraging Machine Learning Approaches to Enable the Commercialization of Epigenetic Biomarkers
AQ
FOXO Technologies Announces Issue Notification from USPTO for a Patent Leveraging Machine Learning Approaches to Enable the Commercialization of Epigenetic Biomarkers
BU
FOXO Technologies™ Interim CEO Mark White Provides Letter to Shareholders Outlining New AI-Enabled Direct-to-Consumer Strategy and Immediate Expense Reductions
BU
FOXO Technologies Announces Agreement With Atrio Insurance
BU
FOXO Technologies Inc. Announces NYSE American Acceptance of Compliance Plan
BU
FOXO Technologies Inc. Announces Receipt of Second Notice of Non-Compliance from NYSE American
BU
FOXO Technologies Collaborates with DataRobot to Pave the Way for AI-Driven Epigenetic Biomarker Research in Human Longevity
AQ
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. FOXO Stock
  4. News FOXO Technologies Inc.
  5. Press Releases
-40% Exceptional extension: Our subscriptions help you unlock the best investment opportunities.
BENEFIT NOW